Deep search
Search
Images
Videos
Maps
News
Shopping
Copilot
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
The Health Risks and Benefits of Weight-Loss Drugs
Read More: Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs
Obesity drugs: huge study highlights new health risks
Weight-loss medicines such as Ozempic might raise a person’s likelihood of developing conditions including arthritis.
Ozempic: Landmark study unveils risk and benefits of popular obesity drug
Debate over the risks and benefits of the population weight loss drugs like Ozempic, Wegovy, and Zepbound finally came to an end after a new landmark study.According to Global News, a new observational study published in the journal
Landmark Study Reveals New Benefits and Risks of Obesity Drugs Like Ozempic
A study by the Department of Veterans Affairs says that drugs like Ozempic can do plenty more than just help with weight loss.
Weight-loss drugs linked to unexpected benefits and risks
The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks of addiction.
What’s behind the meteoric rise of weight-loss drugs in Massachusetts?
About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent increase from 2023, according to a Globe analysis of insurance claims data.
Blockbuster weight-loss drugs linked to lower risk of addiction, schizophrenia, dementia, and more
While weight-loss drugs were linked to lower risk of some conditions, they were also associated with some adverse health outcomes. View on euronews
New Weight Loss Drugs May Fight Obesity-Related Cancer, Too
Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.
GLP-1 weight loss drugs linked to a wide range of health benefits and risks: study
A new peer-reviewed study based on data from nearly 2M individuals highlights a wide range of clinical benefits and risks, including several newly found conditions linked to the GLP-1 class of weight loss and diabetes drugs.
22h
Are we nearing peak obesity as weight loss drugs gain popularity?
As weight loss medications like Ozempic and Wegovy become increasingly popular, questions arise about whether the nation is approaching pea ...
10h
on MSN
Weight-loss treatment for children with obesity has lasting effects, finds study
When children with obesity undergo weight-loss treatment, the results have effects later in life, and the risk of serious ...
9h
on MSN
Weight loss and the changing landscape of medical solutions | Real Men Wear Gowns
Nearly 70% of adults in Indiana are classified as overweight or obese, contributing to a broader health crisis in the United ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Los Angeles wildfire updates
California fires: How to help
Coast Guard chief fired
Milley's portrait taken down
Agent fatally shot in VT
Gulf Coast winter storm
Former prosecutor faces trial
National championship win
Elise Stefanik testifies
Released from prison
Birthright citizenship suit
Fire at ski resort in Turkey
Judge blocks report release
Israel’s top general resigns
'Days of Our Lives' star dies
Acting defense secretary
SCOTUS grants new hearing
Discuss strengthening ties
Raising prices again
FDA approves nasal spray
Silk Road founder pardoned
Trailblazing cartoonist dies
Can target schools, churches
CBP One app shut down
To host '25 Grammy Awards
Antisemitism lawsuits settled
Djokovic beats Alcaraz
1st Japanese elected to HOF
Doug Collins hearing
The Band's keyboardist dies
Israel raids West Bank
Feedback